Bronchodilator reversibility to low and high doses of terbutaline and ipratropium bromide in patients with chronic obstructive pulmonary disease.

BACKGROUND--There is uncertainty regarding the use of monotherapy or combination therapy with beta 2 agonists and anticholinergic drugs in patients with chronic obstructive pulmonary disease (COPD). The measurement of forced expiratory volume in one second (FEV1) or relaxed vital capacity (RVC) in t...

Descrición completa

Detalles Bibliográficos

Publicado en:	Thorax
Principais autores:	Newnham, D. M., Dhillon, D. P., Winter, J. H., Jackson, C. M., Clark, R. A., Lipworth, B. J.
Formato:	Artigo
Idioma:	Inglês
Publicado:	BMJ Publishing Group 1993
Assuntos:	Research Article
Acceso en liña:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC464905/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8296260/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/thx.48.11.1151
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!